‘Pharma Bro’ backs down: Martin Shkreli will roll back outrageous Daraprim price gouge

Problem is.. He’s not the only one and it’s not the only drug.
Turing Pharmaceuticals CEO Martin Shkreli said on Tuesday that he would not go through with his plan to raise the price of the anti-cancer drug Daraprim to $750 per pill, NBC News reported.
September 23, 2015 at 03:19AM from Facebook http://ift.tt/1LMydYy

Leave a Reply